Straits Times Index
3,316.94 +9.04 (+0.27%) Nikkei
39,087.79 +470.69 (+1.22%) Hang Seng
18,912.63 -282.97 (-1.47%) FTSE 100
8,370.33 -46.12 (-0.55%) Bitcoin USD
69,443.47 -271.48 (-0.39%) CMC Crypto 200
1,515.17 -11.25 (-0.74%)
TELA Bio, Inc. (TELA)
After hours:
- GlobeNewswire
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer. In this role, Mr. Firestone will oversee the Company’s commercial operations, including key product launches, sales team training, market development, as well as strategic initiatives to optimize market access
- Insider Monkey
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript May 11, 2024 TELA Bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter 2024 Earnings Conference Call. […]
- Simply Wall St.
TELA Bio First Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.63 loss in 1Q 2023)
TELA Bio ( NASDAQ:TELA ) First Quarter 2024 Results Key Financial Results Revenue: US$16.6m (up 39% from 1Q 2023). Net...
